Major cardiovascular events associated with anti-IL 12/23 agents: a tale of two meta-analyses

J Am Acad Dermatol. 2013 May;68(5):863-5. doi: 10.1016/j.jaad.2013.01.011.
No abstract available

Publication types

  • Meta-Analysis
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Cardiovascular Diseases / chemically induced*
  • Humans
  • Interleukin-12 / antagonists & inhibitors
  • Interleukin-23 / antagonists & inhibitors
  • Psoriasis / drug therapy*
  • Randomized Controlled Trials as Topic
  • Ustekinumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interleukin-23
  • Interleukin-12
  • briakinumab
  • Ustekinumab